Olympian: A Phase 2, Multicenter, Open-Label Study To Assess The Efficacy And Safety Of Neoadjuvant Olaparib Monotherapy And Olaparib Plus Durvalumab In Patients With Brca Mutations And Early-Stage Her2-Negative Breast Cancer
Olaparib;Durvalumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Olympian: A Phase 2, Multicenter, Open-Label Study To Assess The Efficacy And Safety Of Neoadjuvant Olaparib Monotherapy And Olaparib Plus Durvalumab In Patients With Brca Mutations And Early-Stage Her2-Negative Breast Cancer ### Output: Olaparib;Durvalumab